Consistently, IGF2BP1 expression is associated with poor prognosis in various human cancers and the protein enhances the growth and metastasis of human tumor-derived cells in nude mice, as demonstrated for epithelial ovarian cancer (EOC) as well as hepatocellular carcinoma (HCC) derived tumor cells (6,10). This evidence concerns the gene IGF2BP1 and cancer.